NCT05933434View on ClinicalTrials.gov

Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2030

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

Allogenic adipose derived mesenchymal stem cells (AD-MSC)

Laboratory isolated, cultivated and cryopreserved allogenic adipose derived mesenchymal stem cells (AD-MSC) from health donors undergoing cometic plastic surgery will be thawed on the injection day and formulated in 10 mL saline. The AD-MSCs will then be intraarticular injected using ultrasonic guidance.

OTHER

Saline

10 mL saline will be intraarticular injected using ultrasonic guidance.

Trial Locations (1)

8200

RECRUITING

Aarhus University, Aarhus N

All Listed Sponsors
lead

Aarhus University Hospital

OTHER